State of the Science Summit - Breast Cancer: Chaired by Maryam Lustberg, MD, MPH

Commentary
Article

In Partnership With:

State of the Science Summit - Breast Cancer: Chaired by Maryam Lustberg, MD, MPH

State of the Science Summit - Breast Cancer: Chaired by Maryam Lustberg, MD, MPH

Speakers

  • Eric Winer, MD | Yale Cancer Center, Smilow Cancer Hospital
  • Ian Krop, MD, PhD | Yale Cancer Center, Smilow Cancer Hospital
  • Mariya Rozenblit, MD | Yale Cancer Center, Smilow Cancer Hospital
  • Patricia A. DeFusco, MD | Hartford Healthcare Cancer Institute
  • Adriana Matutino Kahn, MD | Yale Cancer Center, Smilow Cancer Hospital
  • Daniel O’Neil, MD, MPH | Yale Cancer Center, Smilow Cancer Hospital

Topics

  • Early HER2+ Treatment
  • Use of ADCs in the Treatment of Metastatic Breast Cancer: Current Status and Future Directions
  • Use of Adjuvant CDK 4/6 Inhibition in High-Risk HR+/HER2- Early-Stage Breast Cancer
  • Treatment Crossroads: What is your approach to treating patients after CDK 4/6 progression?
  • Management of Early-Stage TNBC: Where are we now and where are we going?
  • Year in Review: Updates in Breast Cancer
  • Global Breast Health Issues

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
A panel of 5 experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Ko Un “Clara” Park, MD